Ascentage Pharma Seeking HK$1.5 Billion via Stock Sale; Shares Fall 6% in Pre-market Trade
MT Newswires Live
Jul 15
Ascentage Pharma Group International (HKG:6855) is looking to raise around HK$1.51 billion via the sale of shares, according to a Hong Kong bourse filing Tuesday.
Shares of the company fell nearly 6% in morning trade Tuesday.
The pharmaceutical company is looking to sell 22 million shares at HK$68.60 each to raise the funds which will be used to commercialize the recently approved lisaftoclax in China and to pursue clinical development of other drugs.
The shares represent 6.29% of the firm's existing issued share capital.
J.P. Morgan Securities (Asia Pacific) and Citigroup Global Markets were hired as the placing agents for the offering.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.